Orexigen Therapeutics Reviews

Recommend to a friend
Approve of CEO
Orexigen Therapeutics President, CEO, and Director Michael A. Narachi
Michael A. Narachi
1 Rating
  • Helpful (3)

    Excellent company to work. Typical start up risks but Management is top notch.

    • Work/Life Balance
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Orexigen Therapeutics

    Approves of CEO
    Approves of CEO


    Entrepreneurial atmosphere is contagious and well received by all.


    Travel schedule can ve very brutal for a virtual company.

Orexigen Therapeutics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.orexigen.com
Headquarters La Jolla, CA
Size 50 to 149 Employees
Founded Unknown
Type Company - Public (OREX)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

Orexigen Therapeutics thinks it has the skinny on how to stay trim. The company is developing drugs, under the names Contrave and Empatic (formerly Excalia), intended for use by obese people who are trying to get a grip on the urge to over-eat. The products are designed to control appetite from the central nervous system and contain some of the same chemicals used in drugs approved for the treatment of smoking, alcoholism, and opiate addiction. The development-stage company is conducting late-stage clinical trials on its top two drug candidates.

Work at Orexigen Therapeutics? Share Your Experiences

Orexigen Therapeutics

Click to Rate